269 related articles for article (PubMed ID: 10858224)
1. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice.
Hölscher C; Mohrs M; Dai WJ; Köhler G; Ryffel B; Schaub GA; Mossmann H; Brombacher F
Infect Immun; 2000 Jul; 68(7):4075-83. PubMed ID: 10858224
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.
Hunter CA; Slifer T; Araujo F
Infect Immun; 1996 Jul; 64(7):2381-6. PubMed ID: 8698455
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
4. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18.
Müller U; Köhler G; Mossmann H; Schaub GA; Alber G; Di Santo JP; Brombacher F; Hölscher C
J Immunol; 2001 Sep; 167(6):3346-53. PubMed ID: 11544324
[TBL] [Abstract][Full Text] [Related]
5. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock.
Jacobs F; Dubois C; Carlier Y; Goldman M
Clin Exp Immunol; 1996 Feb; 103(2):233-8. PubMed ID: 8565305
[TBL] [Abstract][Full Text] [Related]
6. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.
Hunter CA; Ellis-Neyes LA; Slifer T; Kanaly S; Grünig G; Fort M; Rennick D; Araujo FG
J Immunol; 1997 Apr; 158(7):3311-6. PubMed ID: 9120288
[TBL] [Abstract][Full Text] [Related]
7. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.
Li C; Sanni LA; Omer F; Riley E; Langhorne J
Infect Immun; 2003 Sep; 71(9):4850-6. PubMed ID: 12933825
[TBL] [Abstract][Full Text] [Related]
8. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
Campos MA; Closel M; Valente EP; Cardoso JE; Akira S; Alvarez-Leite JI; Ropert C; Gazzinelli RT
J Immunol; 2004 Feb; 172(3):1711-8. PubMed ID: 14734753
[TBL] [Abstract][Full Text] [Related]
9. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
[TBL] [Abstract][Full Text] [Related]
11. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
Antúnez MI; Cardoni RL
Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
[TBL] [Abstract][Full Text] [Related]
12. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
[TBL] [Abstract][Full Text] [Related]
13. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
[TBL] [Abstract][Full Text] [Related]
14. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
Front Immunol; 2020; 11():306. PubMed ID: 32194558
[TBL] [Abstract][Full Text] [Related]
15. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.
Hölscher C; Köhler G; Müller U; Mossmann H; Schaub GA; Brombacher F
Infect Immun; 1998 Mar; 66(3):1208-15. PubMed ID: 9488415
[TBL] [Abstract][Full Text] [Related]
16. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils.
Tosello Boari J; Amezcua Vesely MC; Bermejo DA; Ramello MC; Montes CL; Cejas H; Gruppi A; Acosta Rodríguez EV
PLoS Pathog; 2012; 8(4):e1002658. PubMed ID: 22577359
[TBL] [Abstract][Full Text] [Related]
17. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission.
Volta BJ; Bustos PL; González C; Natale MA; Perrone AE; Milduberger N; Laucella SA; Bua J
J Infect Dis; 2021 Sep; 224(6):1086-1095. PubMed ID: 33528501
[TBL] [Abstract][Full Text] [Related]
18. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice.
Graefe SE; Jacobs T; Gaworski I; Klauenberg U; Steeg C; Fleischer B
Microbes Infect; 2003 Aug; 5(10):833-9. PubMed ID: 12919851
[TBL] [Abstract][Full Text] [Related]
20. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
